ClinConnect ClinConnect Logo
Search / Trial NCT06360536

Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women

Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Apr 10, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a new type of exercise program called remotely delivered resistance training, specifically designed for Black women who are experiencing health issues like being overweight, prediabetes, or high blood pressure. The goal is to see if this program is easy for participants to follow, if they find it helpful, and how it might improve their health. This trial is not recruiting participants yet but plans to include women aged 30 to 64 who identify as Black or African American, have not been exercising regularly, and have a diagnosis of at least one of the specified health conditions.

To take part in the study, women need to have access to an internet-connected device, like a smartphone or computer, and be willing to use it for the program. Before joining, they may need to check with their doctor to ensure it's safe for them to exercise. Participants will work out from home and be asked to record their sessions. It's important to note that women who are pregnant, have uncontrolled high blood pressure, or plan to move away soon won't be eligible. This study aims to support Black women in improving their health through accessible exercise options.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Self-identifies as Black or African American
  • Female
  • Age 30-64 years
  • Insufficient resistance training engagement (\<2 sessions/week in the past 6 months)
  • AND
  • Self-reported or documented diagnosis of at least one of the following conditions: Overweight, obesity, prediabetes, type 2 diabetes, elevated blood pressure, hypertension, or taking medications for any of these conditions
  • Has an internet- connected device (i.e., computer, smartphone) and is willing to use it for intervention delivery
  • If indicated during screening, willing to obtain medical clearance for exercise from their healthcare provider prior to enrollment
  • Residing within a 50-mile radius of the University
  • Exclusion Criteria:
  • Uncontrolled hypertension (blood pressure \>160/100 mm Hg)
  • Weighing ≥ 450 lbs (upper limit for body composition assessment)
  • Conditions or limitations that affect physical activity participation and/or the ability to --perform assessments
  • Has a medical or physical condition that make moderate intensity physical activity (like a brisk walk) difficult or unsafe
  • Unwilling to obtain medical clearance (if indicated by prescreening)
  • Women who are pregnant or trying to become pregnant in the next 6 months
  • Planning to relocate out of the area in the next 6 months
  • Participating in another exercise and/or randomized research project
  • Unwilling or unable to do any of the following: give informed consent; read/understand English; perform resistance training in their home, record and upload virtual exercise assessment sessions, and other protocol specific requirements

About University Of Alabama At Birmingham

The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.

Locations

Birmingham, Alabama, United States

Patients applied

0 patients applied

Trial Officials

Amber W Kinsey, PhD

Principal Investigator

University of Alabama at Birmingham

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported